Showing results (721-730 of 1,000) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|March 14, 2008
An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletionColleen A McNaney, Dieter M Drexler, Serhiy Y Hnatyshyn, et al.
Assay and Drug Development Technologies|September 1, 2009
Label-free high-throughput screening via mass spectrometry: a single cystathionine quantitative method for multiple applicationsTom G Holt, Bernard K Choi, Neil S Geoghagen, et al.
Assay and Drug Development Technologies|June 25, 2026
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut MicrobiotaNingning Xie, Yahan Zhang
Assay and Drug Development Technologies|May 28, 2026
Comprehensive Physicochemical Characterization and Release Kinetics of an Astaxanthin Nanoplex: Integrated In Silico and In Vitro EvaluationManish Arora, Chetna Hemrajani, Anshul Jamwal, et al.
Assay and Drug Development Technologies|March 16, 2007
High capacity homogeneous non-radioactive cortisol detection assays for human 11beta-hydroxysteroid dehydrogenase type 1Violeta Yu, Yanyan Tudor, Clarence Hale, et al.
Assay and Drug Development Technologies|July 23, 2026
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon CancerShabnoor Iqbal, Usman Khan
Assay and Drug Development Technologies|December 16, 2014
Bioluminescent cell-based NAD(P)/NAD(P)H assays for rapid dinucleotide measurement and inhibitor screeningJolanta Vidugiriene, Donna Leippe, Mary Sobol, et al.
Assay and Drug Development Technologies|June 25, 2015
Examining Ligand-Based Stabilization of Proteins in Cells with MEK1 Kinase InhibitorsDouglas S Auld, Christopher A Davis, Marta Jimenez, et al.
Assay and Drug Development Technologies|February 8, 2011
Development and utilization of activated STAT3 detection assays for screening a library of secreted proteinsNatalie Fursov, Irina V Gates, Tadas Panavas, et al.
Assay and Drug Development Technologies|December 17, 2010
Triphenylphosphine oxide is a potent and selective inhibitor of the transient receptor potential melastatin-5 ion channelR Kyle Palmer, Karnail Atwal, Ivona Bakaj, et al.
Pageof 100